Higher Quality Evidence to Guide Our Management of Postural Orthostatic Tachycardia Syndrome
- 15 February 2021
- journal article
- editorial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 77 (7), 872-874
- https://doi.org/10.1016/j.jacc.2020.12.028
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia SyndromeJournal of the American College of Cardiology, 2021
- Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic IntoleranceCanadian Journal of Cardiology, 2020
- Vagal and Sympathetic Function in Neuropathic Postural Tachycardia SyndromeHypertension, 2019
- The face of postural tachycardia syndrome – insights from a large cross‐sectional online community‐based surveyJournal of Internal Medicine, 2019
- Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomized Clinical TrialNeurotherapeutics, 2018
- 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal SyncopeHeart Rhythm, 2015
- Propranolol Decreases Tachycardia and Improves Symptoms in the Postural Tachycardia SyndromeCirculation, 2009
- The hemodynamic and neurohumoral phenotype of postural tachycardia syndromeNeurology, 2007
- Renin-Aldosterone Paradox and Perturbed Blood Volume Regulation Underlying Postural Tachycardia SyndromeCirculation, 2005